Results 71 to 80 of about 50,688 (281)
Complete mesocolic excision does not increase short-term complications in laparoscopic left-sided colectomies : a comparative retrospective single-center study [PDF]
, 2019 Background: Since the implementation of total mesorectal excision (TME) in rectal cancer surgery, oncological outcomes improved dramatically. With the technique of complete mesocolic excision (CME) with central vascular ligation (CVL), the same surgical ...Claeys, Donald, Defoort, Barbara, Dewulf, Maxime, Kalmar, Alain, Muysoms, Filip, Pletinckx, Pieter, Vandenberk, Bert +6 morecore +2 more sourcesIncreasing trend in admission rates and costs for acute diverticulitis during 2005–2015: real-life data from the Abruzzo Region
Therapeutic Advances in Gastroenterology, 2018 Background: Scarce data are available on the epidemiological trend of diverticulitis and its financial burden in Italy. The aim of this work was to explore a potential variation in the rate and costs of hospital admissions for uncomplicated and ...Simona Cammarota, Martina Cargiolli, Paolo Andreozzi, Bernardo Toraldo, Anna Citarella, Maria Elena Flacco, Gian Andrea Binda, Bruno Annibale, Lamberto Manzoli, Rosario Cuomo +9 moredoaj +1 more sourceSmoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study. [PDF]
PLoS ONE, 2016 Cigarette smoking increases the risk of surgery in Crohn's disease. However, the effect of smoking on the need for surgery for diverticulitis is unknown.We evaluated whether smoking was a risk factor for surgery among patients admitted to hospital with ...Michael J Diamant, Samuel Schaffer, Stephanie Coward, M Ellen Kuenzig, James Hubbard, Bertus Eksteen, Steven Heitman, Remo Panaccione, Subrata Ghosh, Gilaad G Kaplan +9 moredoaj +1 more sourceEfficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study
Asia-Pacific Journal of Clinical Oncology, EarlyView.RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background
Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...Samantha Kurniawan, Angela Hwang, Nicole Wong Doo, Tracy King, Christian Bryant, Jennifer Zhang, Kristina Whelan, Parisa Fani‐Molky, Giselle Kidson‐Gerber, Annmarie Bosco, Nada Hamad, Gurdeep Parmar, Fiona Kwok, Sam Lai, Silvia Ling, P. Joy Ho, Georgia McCaughan, Adam Bryant +17 morewiley +1 more sourceDNA Methylation Analysis Validates Organoids as a Viable Model for Studying Human Intestinal Aging. [PDF]
, 2020 Background & aimsThe epithelia of the intestine and colon turn over rapidly and are maintained by adult stem cells at the base of crypts. Although the small intestine and colon have distinct, well-characterized physiological functions, it remains ...Coppola, Giovanni, Horvath, Steve, Jones, D Leanne, Lewis, Sophia K, Martin, Martin G, Nachun, Daniel +5 morecore Elective Surgery for Diverticulitis in Swiss Hospitals
Frontiers in Surgery, 2021 Objective: To assess current management of diverticulitis in Switzerland.Methods: Prospective observational study of diverticulitis management and outcomes in surgical departments over a 3-month time period.Seraina Faes, Martin Hübner, Nicolas Demartines, Dieter Hahnloser, David Martin, The Swiss Snapshot Diverticulitis Group, Paolo Abitabile, Dritan Abrazhda, Michele Arigoni, Vahid Bakhshi-Tahami, Jean-Pierre Barras, Thomas Beck, Vincent Bettschart, Paul Biegger, Karin Bläuer, Stefan Breitenstein, Franziska Brinkmann, Lukas Brügger, Hans Brunner, Walter Brunner, Claude Bussard, Jean-Marie Calmes, Jean-Pierre Chevalley, Michael Chilcott, Denis Christinaz, Dimitri Christoforidis, Carlo Coduri, Nadine Crivelli, Aris D'Ambrogio, Branimir Damjanovic, Wiebke Decking, Diego De Lorenzi, Charles de Montmollin, Sona Deretti, Alexandre Descloux, Urs Diener, Marco Di Lazzaro, Luca Di Mare, Rok Dolanc, Andrea Donadini, Georg Donner, Bernhard Egger, Michel Erne, Fabrizio Fasolini, Charlotte-Ulrike Finkenzeller, Ivo Ralf Fischer, Daniel Frey, Raffaele Galli, Walter Gantert, Alain Garcia, Jörg Genstorfer, Pascal Gervaz, Bijan Ghavami, Nicola Ghisletta, Duri Gianom-Campell, Mauro Giuliani, Christine Glaser, Emanuel Gmür, Federico Goti, Jürg Gresser, Felix Grieder, Gerald Gubler, Adriano Guerra, Silvio Gujer, Jürg Gurzeler, Susanne Habelt, Peter Häfliger, Andres Heigl, Dominik Heim, Juliette Henri, Mark Henschel, Rudolf Herzig, Franc Hetzer, Henry Hoffmann, Markus Huber, Regula Humm, Adrienne Imhof, Daniel Inderbitzin, Manuel Jakob, Renata Jori, Philomena Kastner, Andreas Keerl, Ulf Kessler, Philipp Kirchhoff, Jennifer Klasen, Katrin Kleinschmidt, Jürg Knaus, Markus Koch, Michael Kodsi, Erwin Kohlberger, Stefan Kull, Beat Künzli, Sebastian Lamm, Stéphanie Laperrousaz, André Leuenberger, Patrick Mäder, Styliani Mantziari, Florian Martens, Lukas Marti, Olivier Martinet, Jean Mégevand, Gian Melcher, Antoine Meyer, Pierre Meyer, Philippe Morel, Murielle Mormont, Beat Muggli, Markus Müller, Stephan Müller, Andrew Munday, Surennaidoo Naiken, Antonio Nocito, Peter Nussbaumer, Daniel Oertli, Alexandre Paroz, Angelo Pelloni, Jörg Peltzer, Matthias Peter, Sebastian Pohle, Philippe Posso, Hervé Probst, Alexander Radke, Martin Reber, Luca Regusci, Verena Reichl, Andreas Remiger, Jean-Claude Renggli, Monika Richter, Paavo Rillmann, Frédéric Ris, Nadja Ristagno, Luca Rondi, Robert Rosenberg, Raffaele Rosso, Alend Saadi, Bernd Schenkluhn, Martin Schilling, Rolf Schlumpf, Bruno Schmied, Michael Schmitz, Rémi Schneider, Othmar Schöb, Claudio Soravia, René Spalinger, Rudolf Steffen, Daniel Steinemann, Reto Stocker, Ulrich Stricker, Alexander Stupnicki, Michel Suter, Daniel Tassile, Adrien Tempia, Derya Topal, Rebekka Troller, Daniel Trötschler, Cédric Vallet, Denise Vettorel, Carsten Viehl, Peter Villiger, Peter Vogelbach, Marco von Strauss und Torney, Stephan Vorburger, Matthias Walting, Markus Weber, Heinz Wehrli, Bernhard Widmann, Stefan Wildi, Alessandro Wildisen, Bernd Wilhelm, Mariano Winckler, Marc Worreth, Jörg Wydler, Sidika Yakarisik, Urs Zingg, Christof Zöllner, Markus Zuber, Michael Zünd +176 moredoaj +1 more sourceLong‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria
Allergy, EarlyView.Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...Ana M. Gimenez‐Arnau, Marcus Maurer, Adam Reich, Chia‐Yu Chu, Diana Deleanu, Gordon Sussman, Jorge Sanchez, Knut Brockow, Koremasa Hayama, Michihiro Hide, Mohamed Denguezli, Raisa Meshkova, Roberta F. J. Criado, Sarbjit Saini, Solange Valle, Eva Hua, Pengpeng Wang, Alis Burciu, Isabelle Indermuehle, Vineeth Varanasi, Yolandi Joubert, Thomas Severin, Manmath Patekar +22 morewiley +1 more source